Showing results (21-30 of 163) with videos related to

Sort By:
Pageof 17
Therapeutic Advances in Medical Oncology|December 9, 2020
Retreatment with immune checkpoint inhibitors in solid tumors: a systematic reviewKaili Yang, Jiarui Li, Zhao Sun, et al.
Frontiers of Medicine|July 1, 2022
Estimating the number of Chinese cancer patients eligible for and benefit from immune checkpoint inhibitorsKaili Yang, Jiarui Li, Lin Zhao, et al.
Frontiers in Oncology|June 21, 2023
Clinical features and prognosis of lung cancer in patients with connective tissue diseases: a retrospective cohort studyNingning Li, Liwei Gao, Chunmei Bai, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 16, 2015
ROS-mediated activation of JNK/p38 contributes partially to the pro-apoptotic effect of ajoene on cells of lung adenocarcinomaYingyi Wang, Zhao Sun, Shuchang Chen, et al.
Annals of Translational Medicine|April 21, 2020
Health status of middle-aged and older cancer survivors: a nationwide cross-sectional study from the China Health and Retirement Longitudinal Study (CHARLS)Jiarui Li, Haiyu Pang, Zhao Sun, et al.
Onkologie|November 23, 2011
Interdigitating dendritic cell sarcoma: case report with review of the literatureJianfeng Zhou, Weixun Zhou, Chunmei Bai, et al.
Oncology Letters|August 20, 2019
Response prediction to oxaliplatin plus 5-fluorouracil chemotherapy in patients with colorectal cancer using a four-protein immunohistochemical modelJunjie Gu, Zhe Li, Jianfeng Zhou, et al.
Frontiers in Oncology|August 1, 2020
Efficacy of Immune Checkpoint Inhibitors in Non-small-cell Lung Cancer Patients With Different Metastatic Sites: A Systematic Review and Meta-AnalysisKaili Yang, Jiarui Li, Chunmei Bai, et al.
Clinical and Experimental Medicine|April 4, 2023
Effect of age on the risk of immune-related adverse events in patients receiving immune checkpoint inhibitorsKaili Yang, Jiarui Li, Zhao Sun, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 16, 2017
Up regulation of IL-6 is involved in di (2-ethylhexyl) phthalate (DEHP) induced migration and invasion of non small cell lung cancer (NSCLC) cellsYingyi Wang, Ming Zhao, Jieying Liu, et al.
Pageof 17